On March 27, 2017, Zeon Corporation announced a prototype-molding service for plastic microfluidic chips made with its transparent cyclo-olefin polymers ZEONEX and ZEONOR. The company positioned the service for developers of medical examination and diagnostic products, including devices for pharmaceutical design. [S1][S2]
Zeon said the polymers' optical properties, including low fluorescence, suited them to precise molding for optical and medical packaging. It also described the materials as appropriate for DNA/RNA examination devices. Those are the supplier's material claims, not published results from a test of the prototype service. [S1]
The announcement establishes an offer to mold prototypes, not a validated diagnostic product. It gives no service price or measured device performance, and reports no clinical validation. For teams weighing an early design, the distinction matters: prototype access can help explore a format, but the release alone cannot establish whether a finished test will be accurate or ready for use. [S1]
Source documents
- Zeon Launches a Prototype Service for the Production of Microfluidic Chipshttps://www.zeon.co.jp/en/news/assets/pdf/170327.pdf
- Zeon official news archive entry for the March 27, 2017 releasehttps://www.zeon.co.jp/en/news/